IRG1/itaconate/NRF2/GSH axis in tumor-associated macrophages drives therapy resistance and immune evasion in BRCA1-deficient breast cancer

Yabing Nan(Harvard University), Jean J. Zhao(Harvard University)

bioRxiv (Cold Spring Harbor Laboratory)

October 15, 2025

10.1101/2025.10.14.682312

Cited by 0

Related Papers

COT drives resistance to RAF inhibition through MAP kinase pathway reactivation

|Nature|2010|1.4k

Integrative Genomic Approaches Identify IKBKE as a Breast Cancer Oncogene

|Cell|2007|628

The oncogenic properties of mutant p110α and p110β phosphatidylinositol 3-kinases in human mammary epithelial cells

|Proceedings of the National Academy of Sciences|2005|327

Lactate regulates cell cycle by remodelling the anaphase promoting complex

|Nature|2023|200

MELK is not necessary for the proliferation of basal-like breast cancer cells

|eLife|2017|194